HNSPF
Price
$2.45
Change
+$0.29 (+13.43%)
Updated
Feb 20 closing price
Capitalization
9.59B
HTSUY
Price
$6.75
Change
-$0.34 (-4.80%)
Updated
Jan 6 closing price
Capitalization
1.96B
Ad is loading...

HNSPF vs HTSUY

Header iconHNSPF vs HTSUY Comparison
Open Charts HNSPF vs HTSUYBanner chart's image
Hansoh Pharmaceutical Group
Price$2.45
Change+$0.29 (+13.43%)
Volume$2K
Capitalization9.59B
Hisamitsu Pharmaceutical
Price$6.75
Change-$0.34 (-4.80%)
Volume$525
Capitalization1.96B
HNSPF vs HTSUY Comparison Chart
Loading...
View a ticker or compare two or three
VS
HNSPF vs. HTSUY commentary
Feb 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HNSPF is a Hold and HTSUY is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 24, 2025
Stock price -- (HNSPF: $2.45 vs. HTSUY: $6.75)
Brand notoriety: HNSPF and HTSUY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HNSPF: 181% vs. HTSUY: 119%
Market capitalization -- HNSPF: $9.59B vs. HTSUY: $1.96B
HNSPF [@Pharmaceuticals: Other] is valued at $9.59B. HTSUY’s [@Pharmaceuticals: Other] market capitalization is $1.96B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.61B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HNSPF’s FA Score shows that 1 FA rating(s) are green whileHTSUY’s FA Score has 1 green FA rating(s).

  • HNSPF’s FA Score: 1 green, 4 red.
  • HTSUY’s FA Score: 1 green, 4 red.
According to our system of comparison, HNSPF is a better buy in the long-term than HTSUY.

Price Growth

HNSPF (@Pharmaceuticals: Other) experienced а +25.64% price change this week, while HTSUY (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.14%. For the same industry, the average monthly price growth was +77.04%, and the average quarterly price growth was +50.35%.

Industries' Descriptions

@Pharmaceuticals: Other (-1.14% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
HNSPF($9.59B) has a higher market cap than HTSUY($1.96B). HNSPF has higher P/E ratio than HTSUY: HNSPF (30.21) vs HTSUY (24.92). HNSPF YTD gains are higher at: 14.851 vs. HTSUY (-4.728). HTSUY has higher annual earnings (EBITDA): 19.8B vs. HNSPF (3.62B). HTSUY has more cash in the bank: 124B vs. HNSPF (20.9B). HTSUY has less debt than HNSPF: HTSUY (1.17B) vs HNSPF (4.13B). HTSUY has higher revenues than HNSPF: HTSUY (139B) vs HNSPF (9.97B).
HNSPFHTSUYHNSPF / HTSUY
Capitalization9.59B1.96B489%
EBITDA3.62B19.8B18%
Gain YTD14.851-4.728-314%
P/E Ratio30.2124.92121%
Revenue9.97B139B7%
Total Cash20.9B124B17%
Total Debt4.13B1.17B354%
TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KIRAX12.25N/A
N/A
Westwood Global Real Estate A
JFEIX33.95-0.16
-0.47%
JPMorgan Europe Dynamic L
CBEJX10.43-0.13
-1.23%
Allspring Large Cap Value CL R6
QCLVX32.17-0.42
-1.29%
Federated Hermes MDT Large Cap Value C
LAAFX19.46-0.32
-1.62%
Lord Abbett Affiliated F

HNSPF and

Correlation & Price change

A.I.dvisor tells us that HNSPF and RMTI have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HNSPF and RMTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HNSPF
1D Price
Change %
HNSPF100%
N/A
RMTI - HNSPF
24%
Poorly correlated
-1.67%
AYURF - HNSPF
11%
Poorly correlated
N/A
AKAN - HNSPF
8%
Poorly correlated
+1.74%
IXHL - HNSPF
5%
Poorly correlated
+0.32%
BFRI - HNSPF
4%
Poorly correlated
-3.48%
More

HTSUY and

Correlation & Price change

A.I.dvisor tells us that HTSUY and MSTH have been poorly correlated (+12% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HTSUY and MSTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HTSUY
1D Price
Change %
HTSUY100%
N/A
MSTH - HTSUY
12%
Poorly correlated
N/A
TKNO - HTSUY
4%
Poorly correlated
-6.76%
BFRI - HTSUY
4%
Poorly correlated
-3.48%
ORXOY - HTSUY
0%
Poorly correlated
N/A
HNSPF - HTSUY
0%
Poorly correlated
N/A
More